Public trial registry of the CCC-Munich

Trial AB11002

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AB11002
World
Full title
:

A prospective, multicenter, randomised, open-label, activecontrolled, two-parallel groups, phase 3 study to compare the efficacy and safety of masitinib to sunitinib in patients with gastrointestinal stromal tumor after progression with imatinib at 400mg as first line  treatment

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C26 Bösartige Neubildung sonstiger und ungenau bezeichneter Verdauungsorgane
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Sonstige,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Philipp Jost Keine Organisationseinheit angegeben Magnifier